Goodrx Holdings Stock News

Prescription-drug-referral platform GoodRx is seeing shares dive after the company reported a disappointing fourth quarter and glum outlook.

Shares of GoodRx Holdings Inc. fell more than 30% in the extended session Monday after the health care company reported adjusted quarterly earnings below Wall Street expectations and sales also disappointed. The company said it lost $39.9 million, or 10 cents a share, in the fourth quarter, compared with a loss of $298.3 million, or 74 cents a share, in the year-ago period. Adjusted for one-time items, GoodRx earned 9 cents a share. Revenue rose 39% to $213.3 million, the company said. Analysts polled by FactSet expected adjusted earnings of 10 cents a share on sales of $218 million. GoodRx guided for revenue growth of about 23% for 2022. "We see significant opportunities to build on our 2021 growth and success to deliver a very strong 2022, reaching more consumers and providers and bringing more value to each stage of the health care journey," GoodRx said in a letter to investors. Separately, the company said that its board approved a share buyback program of up to $250 million. As of Dec. 31, GoodRx had cash and equivalents of $941.1 million, it said.

Shares of GoodRx Holdings Inc. undefined fell more than 30% in the extended session Monday after the health care company reported adjusted quarterly earnings…

GoodRx Holdings (GDRX), a health-tech firm that offers a prescription drug price comparison tool has crashed ~28% in the post market Monday after the company reported lower than…

GoodRx Holdings, Inc. (GDRX) delivered earnings and revenue surprises of -10% and 1.57%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

GoodRx (GDRX) announced a $250M share repurchase program of its class A stock, effective immediately.This program may be modified, suspended or terminated at any time at the discretion…

GoodRx Holdings press release (GDRX): Q4 Non-GAAP EPS of $0.09 misses by $0.01.Revenue of $213.3M (+38.9% Y/Y) misses by $4.21M.Shares -26%.Q1 2022 Guidance: Revenue is expected to…

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX), a leading consumer-focused digital healthcare platform, has released its fourth quarter and full year 2021 financial results and posted a letter to shareholders on the Overview page of its investor relations website at https://investors.goodrx.com. GoodRx management will host a conference call and webcast today at 2:00 pm. Pacific Time (5:00 p.m. Eastern Time) to discuss the results and the Company’s business outlook.

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX), a leading consumer-focused digital healthcare platform, today announced that its Board of Directors approved a share repurchase program with authorization to purchase up to $250 million of its Class A Common Stock, effective immediately. “This share repurchase program demonstrates the confidence we have in the future of our business and our commitment to creating long-term, sustainable value for our shareholders,” said

GoodRx Holdings reported earnings on Monday (Feb. 28) that, at least as far as investors were concerned, were not good enough, even as monthly active consumer counts gained double-digit percentages. C

Goodrx Holdings, Inc. (GDRX) CEO Doug Hirsch on Q4 2021 Results - Earnings Call Transcript

Shares of GoodRx Holdings Inc. GDRX, +4.22% fell more than 30% in the extended session Monday after the health care company reported adjusted quarterly earnings below Wall Street expectations and sale

GoodRx (NASDAQ:GDRX) is scheduled to announce Q4 earnings results on Monday, Feb. 28, after market close.The consensus EPS estimate is $0.10 (+25% Y/Y)

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings Inc. (Nasdaq: GDRX), a leading consumer-focused digital healthcare platform, today announced that executives from the Company will be presenting